Influenza A/H1N1 vaccination response is inadequate in Down syndrome children when the latest cut-off values are used

Pediatric Infectious Disease Journal

Volumn 31, Issue 12, 2012, Pages 1284-1285

  Kusters, Maaike A ^a   Bok, Vinus L A ^b   Bolz, W E A ^c   Huijskens, E G W ^d   Peeters, M F ^d   De Vries, Esther ^a  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b MÁXIMA MEDICAL CENTER   (Netherlands)

^c ELKERLIEK HOSPITAL   (Netherlands)

^d Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

Author keywords

Down syndrome; H1N1; Influenza a vaccination

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; INFLUENZA VACCINE;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CHILD; CHILD HEALTH CARE; CLINICAL ARTICLE; DOWN SYNDROME; FEMALE; HEMAGGLUTINATION; HUMAN; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA VACCINATION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE;

EID: 84870891509     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182737410     Document Type: Article

References (19)

1. Garrison MM, Jeffries H, Christakis DA. Risk of death for children with down syndrome and sepsis. J Pediatr. 2005;147:748-752.
2. Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet. 2002;359:1019-1025.
3. Bertrand P, Navarro H, Caussade S, et al. Airway anomalies in children with Down syndrome: endoscopic findings. Pediatr Pulmonol. 2003;36: 137-141.
4. Brumbaugh DE, Accurso FJ. Persistent silent aspiration in a child with Trisomy 21. Curr Opin Pediatr. 2002; 14:231-233.
5. Chaney RH, Eyman RK, Miller CR. The relationship of congenital heart disease and respiratory infection mortality in patients with Down's syndrome. J Ment Defic Res. 1985;29(pt 1):23-27.
6. Kusters MA, Verstegen RH, Gemen EF, et al. Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol. 2009;156:189-193.
7. Kusters MA, Jol-van der Zijde CM, van Tol MJ, et al. Impaired avidity maturation after tetanus toxoid booster in children with Down syndrome. Pediatr Infect Dis J. 2011;30:357-359.
8. Costa-Carvalho BT, Martinez RM, Dias AT, et al. Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients. Braz J Med Biol Res. 2006;39:1587-1592.
9. Hawkes RA, Boughton CR, Schroeter DR. The antibody response of institutionalized Down's syndrome patients to seven microbial antigens. Clin Exp Immunol. 1978;31:298-304.
10. Philip R, Berger AC, McManus NH, et al. Abnormalities of the in vitro cellular and humoral responses to tetanus and influenza antigens with concomitant numerical alterations in lymphocyte subsets in Down syndrome (trisomy 21). J Immunol. 1986;136:1661-1667.
11. Huijskens E, Rossen J, Mulder P, et al. Immunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy population. Clin Vaccine Immunol. 2011;18:1401-1405.
12. National Institute for Biological Standards and Control. Influenza reagent WHO international standard for antibody to influenza H1N1pdm virus. Version 3.0; 2011.
13. Al-Khayatt R, Jennings R, Potter C W. Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis. J Hyg (Lond). 1984;93:301-312.
14. Black S, Nicolay U, Vesikari T, et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J. 2011;30:1081-1085.
15. Arguedas A, Soley C, Lindert K. Responses to 2009 H1N1 vaccine in children 3 to 17 years of age. N Engl J Med. 2010;362:370-372.
16. Nolan T, McVernon J, Skeljo M, et al. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA. 2010;303:37-46.
17. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361:1945-1952.
18. Centers for Disease Control and prevention. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep. 2009;58:521-524.
19. Meier S, Bel M, L'huillier A, et al.; H1N1 Epidemiology Study Group of Geneva. Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children. Vaccine. 2011;29:3548-3557.